Correlation Between Aquestive Therapeutics and Lantheus Holdings
Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and Lantheus Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and Lantheus Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aquestive Therapeutics and Lantheus Holdings, you can compare the effects of market volatilities on Aquestive Therapeutics and Lantheus Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of Lantheus Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and Lantheus Holdings.
Diversification Opportunities for Aquestive Therapeutics and Lantheus Holdings
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Aquestive and Lantheus is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and Lantheus Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lantheus Holdings and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with Lantheus Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lantheus Holdings has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and Lantheus Holdings go up and down completely randomly.
Pair Corralation between Aquestive Therapeutics and Lantheus Holdings
Given the investment horizon of 90 days Aquestive Therapeutics is expected to generate 1.36 times more return on investment than Lantheus Holdings. However, Aquestive Therapeutics is 1.36 times more volatile than Lantheus Holdings. It trades about 0.09 of its potential returns per unit of risk. Lantheus Holdings is currently generating about 0.04 per unit of risk. If you would invest 91.00 in Aquestive Therapeutics on August 24, 2024 and sell it today you would earn a total of 365.00 from holding Aquestive Therapeutics or generate 401.1% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aquestive Therapeutics vs. Lantheus Holdings
Performance |
| Timeline |
| Aquestive Therapeutics |
| Lantheus Holdings |
Aquestive Therapeutics and Lantheus Holdings Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aquestive Therapeutics and Lantheus Holdings
The main advantage of trading using opposite Aquestive Therapeutics and Lantheus Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, Lantheus Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lantheus Holdings will offset losses from the drop in Lantheus Holdings' long position.| Aquestive Therapeutics vs. Evoke Pharma | Aquestive Therapeutics vs. Dynavax Technologies | Aquestive Therapeutics vs. Amphastar P | Aquestive Therapeutics vs. Lantheus Holdings |
| Lantheus Holdings vs. Neurocrine Biosciences | Lantheus Holdings vs. Ironwood Pharmaceuticals | Lantheus Holdings vs. Alkermes Plc | Lantheus Holdings vs. Avadel Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |